Aronora
Blood & Organ Banks · Oregon, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1818 SW 4th Ave Ste 102, Portland, Orego...Phone Number
(503) 530-6842Website
www.aronorabio.comRevenue
<$5 MillionIndustry
About Aronora
Aronora, Inc. is focused on developing and commercializing innovative therapies for serious hematologic diseases, particularly those with significant unmet medical needs. The company is advancing first-in-class biologic drugs, including AB002 and AB023, which target unique mechanisms of action to address life-threatening blood conditions. Their primary clients include patients with end-stage renal disease requiring anticoagulation during hemodialysis, as well as individuals at risk for thrombotic complications from various medical conditions. Aronora's mission is to create safe and effective treatments that can significantly improve patient outcomes in the field of hematology.Explore more
Aronora Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aronora
Compare insights from companies similar to Aronora, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aronora Tech Stack
A closer look at the technologies used by Aronora
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aronora
Sign Up For FreeTo access detailed company insights
Aronora, Inc. is focused on developing and commercializing innovative therapies for serious hematologic diseases, particularly those with significant unmet medical needs. The company is advancing first-in-class biologic drugs, including AB002 and AB023, which target unique mechanisms of action to address life-threatening blood conditions. Their pri... Read More
